Frank Litvack, M.D.
Board Member
Capricor Therapeutics, Inc. (CAPR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Frank Litvack, M.D.
Frank Litvack, M.D. is recorded as Board Member at Capricor Therapeutics, Inc. (CAPR). Capricor Therapeutics, Inc. reported in an 8-K filed May 27, 2025 that Frank Litvack, M.D. was appointed director, effective May 22, 2025.
“Each of Frank Litvack, M.D., Linda Marbán, Ph.D., David B. Musket, George W. Dunbar, Jr., Karimah Es Sabar, Paul Auwaerter, M.D., Philip Gotwals, Ph.D., and Michael Kelliher were elected as directors of the Company to serve until the 2026 annual meeting of stockholders, and until his or her successor is elected, or until his or her earlier death, resignation or removal, as follows:”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-05-22–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Capricor Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Linda Marban CEO, Board Member
- Frank Litvack Chairman, Board Member
- Anthony "A.J." Bergmann CFO
- Karen G. Krasney General Counsel
- David B. Musket Board Member
- George W. Dunbar Jr Board Member
- George W. Dunbar, Jr. Board Member
- Karimah Es Sabar Board Member
- Linda Marbán, Ph.D. Board Member
- Michael Kelliher Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.